ARCHIVES

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

This article is from The Cancer Letter archive.

Vol. 09 No. 23 | June 10, 1983

Download PDF Visit The Full Archive

Related Articles

Working Group Beings AID-Related Lymphoma research

October 19, 1990

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

No Benefit For Cetuximab In Early-Stage Colon Cancer

December 25, 2009

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977